文献速递神经与头颈病理细胞病理与分子病理

融合驱动的良性外周神经鞘瘤:超越混合形态的大系列研究

Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions.
PubMed 文献 · Mod Pathol · 2025-06-06

该研究纳入20例混合性外周神经鞘瘤(hPNST),中位年龄29.5岁,女性15例、男性5例。二代测序显示14例存在VGLL3融合(以CHD7融合最常见,10例),另发现TEAD1::NCOA2融合及TOX::TEAD1等5种新融合。多数VGLL3融合肿瘤呈经典混合性神经鞘瘤-神经束膜瘤特征,部分形态不典型;RREB1::LPP融合肿瘤呈混合性神经鞘瘤-神经纤维瘤特征,SRF::MYOCD融合肿瘤呈神经与平滑肌双表型。

要点

  • VGLL3融合是hPNST最常见分子事件,CHD7为最常见融合伴侣。
  • VGLL3融合肿瘤多数呈混合性神经鞘瘤-神经束膜瘤形态,少数不典型。
  • RREB1::LPP与SRF::MYOCD等新融合拓展了hPNST分子谱。

核心结论

  • 融合驱动的hPNST形态与分子谱比传统认识更广,包含5种既往未报道的融合。
  • VGLL3融合不仅见于经典混合性神经鞘瘤-神经束膜瘤,也见于形态不典型病例。

研究设计与样本

  • 回顾性系列研究,纳入20例hPNST,女15例、男5例,中位年龄29.5岁(范围3周至71岁)。
  • 采用二代测序检测融合,随访信息可获取9/20例(45%),中位随访10个月(范围2周至144个月)。

主要发现

  • 14例检出VGLL3融合,其中CHD7融合10例、CHD9融合3例、MAMLD1融合1例。
  • 另检出TEAD1::NCOA2融合1例,以及TOX::TEAD1(2例)、RREB1::LPP(1例)、SRF::MYOCD(1例)、KANK1::CDK5RAP2(1例)等新融合。
  • 9例随访中2例(22%)在不完全切除后10个月和144个月出现局部复发。
  • 多数VGLL3融合肿瘤呈经典混合性神经鞘瘤-神经束膜瘤形态及免疫表型,少数呈显著黏液样间质、假脂肪母细胞、显著神经鞘瘤结节或单纯神经鞘瘤形态。
  • RREB1::LPP融合肿瘤呈混合性神经鞘瘤-神经纤维瘤特征,SRF::MYOCD融合肿瘤呈神经与平滑肌双表型。

临床怎么用

  • 对形态学提示混合性外周神经鞘瘤的病例,可考虑行融合基因检测辅助分类。
  • 识别VGLL3融合有助于将部分形态不典型病例归入hPNST谱系。
  • 不完全切除后存在局部复发可能,随访中位10个月时已观察到复发。

局限性

  • 样本量小(20例),随访信息仅覆盖9例(45%),随访时间范围宽。
  • 为单中心回顾性研究,新融合的功能意义尚未验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Benign peripheral nerve sheath tumors (PNSTs) represent a heterogeneous group of neoplasms with varying histologic and molecular characteristics. Although traditional classifications categorize these tumors based on predominant cell types, recent advances in molecular pathology have revealed the presence of hybrid tumors featuring elements from at least 2 nerve sheath tumors (hybrid peripheral nerve sheath tumor [hPNST]). We herein studied 20 cases of hPNST involving 15 female and 5 male patients (median age, 29.5 years; range, 3 weeks-71 years). Tumors occurred on the upper extremity (6), scalp (3), trunk (3), face (3), lower extremity (2), right lateral neck (1), nasal sinus (1), and retroperitoneum (1). Follow-up information was available in 9 of 20 cases (45%; median, 10 months; range, 2 weeks-144 months) and documented local recurrence in 2 of 9 patients (22%) at 10 and 144 months after incomplete excision. Next-generation sequencing demonstrated vestigial-like family member 3 (VGLL3) fusions in 14 cases, fused with CHD7 (10 tumors), CHD9 (3 tumors), and MAMLD1 (1 tumor), an alternative TEAD1::NCOA2 (1 tumor) fusion and several novel fusions including TOX::TEAD1 (2 tumors), RREB1::LPP (1 tumor), SRF::MYOCD (1 tumor), and KANK1::CDK5RAP2 (1 tumor). Most tumors with VGLL3 fusions showed morphologically and immunophenotypically classic features of hybrid schwannoma-perineurioma, whereas rare cases showed unusual microscopic features, such as prominent myxoid stroma, pseudolipoblasts, prominent Schwannian nodules, or solely schwannomatous morphology. The RREB1::LPP-driven tumor showed features of hybrid schwannoma-neurofibroma. Lastly, 1 tumor with a novel SRF::MYOCD fusion displayed morphologic features reminiscent of desmoplastic melanoma although exhibiting a combined neural and smooth muscle phenotype. Our data expand on the morphologic and molecular spectrum of fusion-driven hPNSTs, including 5 previously undescribed fusions, and further expand on noncentral nervous system schwannomas with VGLL3 fusions.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Dehner CA, Platero-Portillo T, Jour G, et al. Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions. Mod Pathol. 2025. PMID: 40484320. doi:10.1016/j.modpat.2025.100806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。